Bowel cancer screening campaign: Wales
To raise awareness of the NHS Wales Bowel Cancer Screening Programme (guaiac Faecal Occult Blood Test/ gFOBT), encourage more people to partici[pate.
Cancers of the large bowel (colon)and back passage (rectum). Also called colorectal cancer or large bowel cancer.
To raise awareness of the NHS Wales Bowel Cancer Screening Programme (guaiac Faecal Occult Blood Test/ gFOBT), encourage more people to partici[pate.
This study is for families who do not have a gene change (mutation) known to increase bowel cancer risk or a family history of bowel cancer.
Incidence rates for bowel cancer in the UK are highest in people aged 85 to 89 (2017-2019).
Each year more than 4 in 10 (43%) of all new bowel cancer cases in the UK are diagnosed in people aged 75 and over (2017-2019).
There are around 44,100 new bowel cancer cases in the UK every year, that's around 120 every day (2017-2019).
Bowel cancer is the 4th most common cancer in the UK, accounting for 11% of all new cancer cases (2017-2019).
In females in the UK, bowel cancer is the 3rd most common cancer, with around 19,600 new cases every year (2017-2019).
In males in the UK, bowel cancer is the 3rd most common cancer, with around 24,500 new cases every year (2017-2019).
This trial is for people with early stage cancer of the back passage (rectum).
31% of patients diagnosed with colon cancer and 42% of patients diagnosed with rectal cancer have chemotherapy as part of their primary cancer treatment.
3% of patients diagnosed with colon cancer and 41% of patients diagnosed with rectal cancer have radiotherapy as part of their primary cancer treatment.
66% of patients diagnosed with colon cancer and 63% of patients diagnosed with rectal cancer have surgery to remove the tumour as part of their primary cancer treatment.